OR7E38P

Across TCGA pan-cancer cohorts, OR7E38P RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of OR7E38P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where OR7E38P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E38P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

COAD, HNSC, and KIRC are the cancer types where OR7E38P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E38P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.548	<.001	12	view →
HNSC	Male	III,IV	+1.304	<.001	12	view →
KIRC	All	IV	+0.897	<.001	12	view →
LUSC	All	III,IV	+1.588	<.001	9	view →
UCEC	All	IV	+2.104	<.001	8	view →
LUAD	Female	III,IV	+1.475	<.001	8	view →
KICH	Female	II,III,IV	−1.308	<.001	8	view →
STAD	All	II,III,IV	+1.084	<.001	8	view →
BLCA	Female	All	+1.056	.004	6	view →
BRCA	Female	All	+0.644	<.001	6	view →
LIHC	Male	All	+0.816	<.001	5	view →
ESCA	All	All	+1.058	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

OR7E38P–COAD

Open the COAD breakdown →